1. Home
  2. IDYA vs STNG Comparison

IDYA vs STNG Comparison

Compare IDYA & STNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • STNG
  • Stock Information
  • Founded
  • IDYA 2015
  • STNG 2009
  • Country
  • IDYA United States
  • STNG Monaco
  • Employees
  • IDYA N/A
  • STNG N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • STNG Marine Transportation
  • Sector
  • IDYA Health Care
  • STNG Consumer Discretionary
  • Exchange
  • IDYA Nasdaq
  • STNG Nasdaq
  • Market Cap
  • IDYA 1.9B
  • STNG 2.2B
  • IPO Year
  • IDYA 2019
  • STNG 2010
  • Fundamental
  • Price
  • IDYA $24.27
  • STNG $43.91
  • Analyst Decision
  • IDYA Strong Buy
  • STNG Buy
  • Analyst Count
  • IDYA 13
  • STNG 4
  • Target Price
  • IDYA $50.82
  • STNG $60.50
  • AVG Volume (30 Days)
  • IDYA 1.0M
  • STNG 1.5M
  • Earning Date
  • IDYA 08-05-2025
  • STNG 07-30-2025
  • Dividend Yield
  • IDYA N/A
  • STNG 3.58%
  • EPS Growth
  • IDYA N/A
  • STNG N/A
  • EPS
  • IDYA N/A
  • STNG 10.31
  • Revenue
  • IDYA $7,000,000.00
  • STNG $1,066,599,000.00
  • Revenue This Year
  • IDYA $115.83
  • STNG N/A
  • Revenue Next Year
  • IDYA $252.50
  • STNG $1.45
  • P/E Ratio
  • IDYA N/A
  • STNG $4.34
  • Revenue Growth
  • IDYA N/A
  • STNG N/A
  • 52 Week Low
  • IDYA $13.45
  • STNG $30.63
  • 52 Week High
  • IDYA $44.42
  • STNG $77.83
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 63.79
  • STNG 54.25
  • Support Level
  • IDYA $21.33
  • STNG $42.54
  • Resistance Level
  • IDYA $25.54
  • STNG $45.29
  • Average True Range (ATR)
  • IDYA 1.00
  • STNG 1.77
  • MACD
  • IDYA 0.20
  • STNG -0.02
  • Stochastic Oscillator
  • IDYA 70.60
  • STNG 45.73

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About STNG Scorpio Tankers Inc.

Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.

Share on Social Networks: